Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,651   4.84  Index Moved Down -0.29%
UNIPHOS COROMANDE BAYER RALLIS Large Growth Silver Precious Metals Real Estate 
United States GSPC USD ...  |  Create Portfolios


Processing
Processing. Please wait...

Camson Current Liabilities

 
 Companies |  Insiders  | Dashboard  
     

Current Liabilities breakdown for Camson

Current Liabilities is company's short term debts. This usually includes obligations that are due within next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Camson

Current Liabilities

=

Payables

+

Accrued Debt

=
182 M
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Compare Camson to competition

Camson Current Liabilities Assessment

In accordance with recently published financial statements Camson Bio Technologies Limited has Current Liabilities of 182 M. This is 97.82% lower than that of Basic Materials sector, and 94.59% lower than that of Agricultural Chemicals industry, The Current Liabilities for all stocks is 97.9% higher than the company.

Filter other Stocks by Current Liabilities

Specify Market Cap
Select Current Liabilities Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

Current Liabilities Comparison

Camson is currently under evaluation in current liabilities category among related companies.
Follow Camson Current Liabilities with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Camson to your reader
 
    
CAMSONBIO India Bombay #INE845E01012IN
Camson Bio Technologies Limited
Benchmark S&P 500
Currency: INR
Traded on Bombay Stock Exchange
    
    

Other Camson Fundamentals

Profit Margin17.74 %
Operating Margin19.22 %
Current Valuation1.31 B
Shares Outstanding18.11 M
Price to Earning6.27 times
Price to Book0.91 times
Price to Sales1.09 times
Revenue1.12 B
Gross Profit644 M
EBITDA236.89 M
Net Income198.58 M
Cash and Equivalents18.82 M
Cash per Share1.04 times
Total Debt273.08 M
Debt to Equity0.20 times
Current Ratio3.92 times
Book Value Per Share74.15 times
One Year High75.8
One Year Low36.5
Earnings Per Share10.96 times
Number of Employees160
Market Capitalization1.24 B
Total Asset1.07 B
Working Capital445 M
Current Asset627 M
Current Liabilities182 M
Z Score3.399
Probability Of Bankruptcy21.89 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium